Can Fite Biopharma
CANF
#9681
Rank
A$19.6 M
Marketcap
$3.22
Share price
3.41%
Change (1 day)
5.44%
Change (1 year)

Can Fite Biopharma (CANF) - Cash on Hand

Cash on Hand as of December 2023 : A$13.53 Million

According to Can Fite Biopharma 's latest financial reports the company has A$13.53 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Can Fite Biopharma - Cash on Hand chart (from 2011 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$11.73 M-55.54%
2021-12-31A$26.39 M143.31%
2020-12-31A$10.85 M175.14%
2019-12-31A$3.94 M-28.55%
2018-12-31A$5.51 M22.93%
2017-12-31A$4.48 M-60.11%
2016-12-31A$11.25 M-51.53%
2015-12-31A$23.21 M105.01%
2014-12-31A$11.32 M69.4%
2013-12-31A$6.68 M506.71%
2012-12-31A$1.1 M-70.59%
2011-12-31A$3.74 M